搜索临床试验以:艾塞那肽、利拉鲁肽
总计782个结果
-
AstraZenecaEli Lilly and Company完全的
-
Hospital Universitari Vall d'Hebron Research Institute完全的
-
James J. Peters Veterans Affairs Medical CenterKessler Institute for Rehabilitation完全的
-
Radboud University Medical CenterTurku University Hospital; Charite University, Berlin, Germany; University Medical Center Groningen 和其他合作者未知
-
xiaolong zhaoShanghai Zhongshan Hospital; Second Affiliated Hospital of Soochow University; Taizhou Hospital; Shanghai Pudong New Area Gongli Hospital 和其他合作者未知
-
Georgetown UniversityMedstar Health Research Institute撤销
-
Bristol-Myers Squibb完全的
-
Eunice Kennedy Shriver National Institute of Child...完全的
-
University of Colorado, DenverNational Center for Advancing Translational Sciences (NCATS)完全的
-
GRADE Study GroupBristol-Myers Squibb; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Novo Nordisk A... 和其他合作者完全的
-
Novo Nordisk A/S主动,不招人
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness Network, Canada完全的
-
Profil Institut für Stoffwechselforschung GmbHSanofi完全的
-
Radboud University Medical CenterUniversity of Coimbra未知
-
Azienda Ospedaliero-Universitaria di ParmaUniversity of Parma招聘中
-
Sun Yat-sen UniversityEli Lilly and Company; Ministry of Health, China; Amylin Pharmaceuticals, LLC.完全的
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...招聘中
-
Nanjing First Hospital, Nanjing Medical University未知
-
Fudan UniversityShanghai Changzheng Hospital; Shanghai 6th People's Hospital; Shanghai Minhang Central Hospital; Huadong Hospital完全的
-
Novo Nordisk A/S完全的2型糖尿病 | 糖尿病美国, 加拿大, 塞尔维亚, 火鸡, 俄罗斯联邦, 印度, 拉脱维亚, 波多黎各, 黎巴嫩, 哥伦比亚
-
University of Texas Southwestern Medical Center完全的
-
Changi General Hospital未知减肥 | 非酒精性脂肪肝(NAFLD) | 非酒精性脂肪性肝炎 (NASH)新加坡
-
Cedars-Sinai Medical CenterNovo Nordisk A/S; The Cure Parkinson's Trust完全的
-
GlaxoSmithKlineWake Forrest Baptist Health终止
-
Eli Lilly and Company完全的